Lifeward Expected to Post $1.08/Share Loss Despite Revenue Growth Ahead of Earnings
LFWD sits 64% above its 52-week low of $4.14.
Summary
Lifeward Ltd. is projected to report a loss of $1.08 per share for the quarter ending December 31, 2025, according to analyst estimates. This comes despite an expected 4.2% increase in revenue to $7.861 million. This earnings preview is significant for the micro-cap company, especially following a recent 1-for-12 reverse stock split and the securing of high-interest debt, indicating ongoing financial challenges. Traders will be closely watching the actual earnings release on March 5th for confirmation of these figures and any forward guidance, as the expected loss is substantial relative to the company's stock price and recent corporate actions.
At the time of this announcement, LFWD was trading at $6.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.3M. The 52-week trading range was $4.14 to $35.40. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.